Hyaluronic acid and chondroitin sulphate instillation in chronic bladder diseases: a meta‐analysis
BJU International · 2026
DOI: 10.1111/bju.70016 ↗Kurz gefasst
Metaanalyse in der Zeitschrift BJU International, 2026. Verfasst von Giovanni Corona und 10 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Unit, Azienda AUSL Bologna, Ospedale Maggiore, Bologna, Italy. Hauptthemen laut MEDLINE: Hyaluronic Acid, Chondroitin Sulfates, Cystitis, Interstitial, Cystitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 89 Literaturangaben.
Abstract (Originalsprache)
Objective
To systematically summarise and meta‐analyse all uncontrolled and controlled studies evaluating the role of intravesical instillation of hyaluronic acid (HA), with or without chondroitin sulphate (ChS), in the treatment of bladder pain syndrome (BPS), recurrent urinary tract infection (rUTI) and post‐radiation cystitis (pRC).
Methods
A systematic review was conducted, and a protocol was registered with PROSPERO (CRD42025640480). Studies published between 1 January 1969 and 31 August 2024 were retrieved from multiple databases. Data were analysed using random‐effects and common‐effects models with subgroup and sensitivity analyses.
Results
A total of 131 studies were retrieved, of which 30, 10 and three investigated the use of HA/ChS in patients with BPS and rUTI or pRC, respectively, and were included in the analyses.
Conclusion
The use of HA/ChS resulted in a significant improvement in pain as well as voiding and irritative symptoms in all the investigated conditions. In addition, the treatment reduced the risk of rUTI when compared to standard care. Although limited data were available, when randomised controlled trials were investigated, the combined use of HA/ChS resulted in better outcomes and a lower infection rate compared to either placebo or standard of care (odds ratio 0.42 [95% CI 0.25; 0.49]; P < 0.0001). Finally, an improvement in sexual function and quality of life was also observed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Unit, Azienda AUSL Bologna, Ospedale Maggiore, Bologna, Italy.
- Department of Urology and Andrology, Ospedale di Circolo and Macchi Foundation, Varese, Italy.
- Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Experimental, Clinical, and Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.
- Department of Urology, Hospital Universitario HM Sanchinarro, HM Hospitales and ROC Clinic, Madrid, Spain.
- Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
- Vita-Salute San Raffaele University, Milan, Italy.
ORCID-Profile: Giovanni Corona, Paolo Capogrosso, Javier Romero-Otero, Andrea Salonia, Yacow Reisman, Mikkel Fode
Zitieren
APA
Corona, G., Capogrosso, P., Baldini, S., Rastrelli, G., Vignozzi, L., Romero-Otero, J., Salonia, A., Reisman, Y., Bettocchi, C., Maggi, M., & Fode, M. (2026). Hyaluronic acid and chondroitin sulphate instillation in chronic bladder diseases: a meta‐analysis. BJU International. https://doi.org/10.1111/bju.70016
Vancouver
Corona G, Capogrosso P, Baldini S, Rastrelli G, Vignozzi L, Romero-Otero J, et al. Hyaluronic acid and chondroitin sulphate instillation in chronic bladder diseases: a meta‐analysis. BJU International. 2026. doi:10.1111/bju.70016
BibTeX
@article{Corona2026,
author = {Corona, Giovanni and Capogrosso, Paolo and Baldini, Sara and Rastrelli, Giulia and Vignozzi, Linda and Romero-Otero, Javier and Salonia, Andrea and Reisman, Yacow and Bettocchi, Carlo and Maggi, Mario and Fode, Mikkel},
title = {Hyaluronic acid and chondroitin sulphate instillation in chronic bladder diseases: a meta‐analysis},
journal = {BJU International},
year = {2026},
doi = {10.1111/bju.70016}
}
EUVIMED